Class II · Moderate risk Ongoing
Sufenta
Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.
All sterile drug preparations remaining within expiry prepared…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of sterility assurance.
What was recalled
All sterile drug preparations remaining within expiry prepared from Sufentanil Citrate Base Solution dispensed between October 16, 2017 and November 17, 2017, Compounded by Intrathecal Compounding Specialists, Scott, LA 70583.
- Recalling firm
- Intrathecal Compounding Specialist, LLC
- Origin
- LA, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0323-2018
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Sufentanil recalls
See all
Class II · Moderate risk Terminated
Sufentanil Citrate Injection
Reason Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.
Class I · High risk Terminated
Hydromorphone Hcl-Bupivacaine Hcl-Sufentanil Pf…
Reason Non-Sterility
Class I · High risk Terminated
Sufentanil-Bupivacaine-Baclofen Pf 25mcg-12.5mg-750mcg/Ml…
Reason Non-Sterility
Class II · Moderate risk Terminated
SUFENTANIL 55.5 MCG/ML IN 18ML INJ in 18 mL syringe Assurance Infusion
Reason Lack of sterility assurance.
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.